Nu-Med Plus (NUMD) Common Equity (2011 - 2025)
Nu-Med Plus' (NUMD) quarterly Common Equity came in at -$271278.0 in Q4 2025, down 26.12% year-on-year from -$367184.8 in Q4 2024, and down 4.88% quarter-over-quarter from -$258660.0 in Q3 2025.
Nu-Med Plus (NUMD) Common Equity (2011 - 2025) Analysis & Trends
Nu-Med Plus has disclosed Common Equity across 15 years of filings, most recently posting -$271278.0 for Q4 2025.
- Common Equity for Q4 2025 came in at -$271278.0, down 26.12% year-over-year; the trailing twelve-month figure through Dec 2025 was -$271278.0 (down 26.12% YoY), and the FY2025 annual result was -$271278.0, down 26.12% from the prior year.
- Common Equity came in at -$271278.0 for Q4 2025 at Nu-Med Plus, down from -$258660.0 in the prior quarter.
- In the past five years, Common Equity ranged from a high of $190955.0 in Q1 2021 to a low of -$271278.0 in Q4 2025.
- The 5-year median for Common Equity is -$177220.5 (2024), against an average of -$152677.1.
- Across the five-year window, Common Equity jumped 151.99% in 2021 and sank 14865.54% in 2022, its largest moves.
- Nu-Med Plus' Common Equity stood at -$132358.0 in 2021, then surged by 52.38% to -$63025.0 in 2022, then tumbled by 132.85% to -$146751.0 in 2023, then plunged by 46.57% to -$215096.0 in 2024, then decreased by 26.12% to -$271278.0 in 2025.
- The last three Common Equity figures came in at -$271278.0 (Q4 2025), -$258660.0 (Q3 2025), and -$246694.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 48.99 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.68 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 7.20 Bn |
| 10 | Nu-Med Plus | - | - | - | -271,278.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -271,278.00 |
| Sep 30, 2025 | -258,660.00 |
| Jun 30, 2025 | -246,694.00 |
| Mar 31, 2025 | -235,029.00 |
| Dec 31, 2024 | -215,096.00 |
| Sep 30, 2024 | -204,541.00 |
| Jun 30, 2024 | -185,864.00 |
| Mar 31, 2024 | -168,577.00 |
| Dec 31, 2023 | -146,751.00 |
| Sep 30, 2023 | -131,955.00 |
| Jun 30, 2023 | -115,549.00 |
| Mar 31, 2023 | -91,229.00 |
| Dec 31, 2022 | -63,025.00 |
| Sep 30, 2022 | -270,131.00 |
| Jun 30, 2022 | -247,081.00 |
| Mar 31, 2022 | -189,011.00 |
| Dec 31, 2021 | -132,358.00 |
| Sep 30, 2021 | -70,017.00 |
| Jun 30, 2021 | -1,651.00 |
| Mar 31, 2021 | 190,955.00 |